Axol Bioscience Ltd

Axol Bioscience has secured $2.8 million (around £2.1 million) in funding, part of which will be used to expand its operations in Edinburgh. The investment was led by US life sciences specialist BroadOak Capital Partners, with the company’s founding investor, the Roslin Foundation, also

Edinburgh-based Censo Biotechnologiesand Axol Bioscience Ltd, an established provider of iPSC-derived cells, media, and characterization services, have announced a merger and subsequent £3.8 million funding round. The new entity will become a leading provider of product and service s